Combination of the drugs at different concentrations in various MDM2-amplified sarcoma cell lines also revealed no synergism with regard to viability of cells (Fig. S1d–g; note that here viability was assayed immediately after 72 h of treatment, without allowing the cells to further proliferate). This evidence concerns the gene MDM2 and sarcoma.